APRINOIA

APRINOIA Therapeutics Inc. is a clinical-stage biopharmaceutical company headquartered in Cambridge, Massachusetts, dedicated to developing highly sensitive and selective diagnostic and therapeutic agents for a wide range of neurodegenerative diseases.